Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

VP3: Vancouver Primary Prevention Program (Anxiety Disorders Prevention in School Children)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00247754
Recruitment Status : Completed
First Posted : November 2, 2005
Last Update Posted : November 2, 2005
Sponsor:
Collaborator:
Canadian Institutes of Health Research (CIHR)
Information provided by:
University of British Columbia

Brief Summary:

Objective:

  1. To evaluate the efficacy of a school-based cognitive behavior therapy (CBT) program in reducing anxiety disorder symptoms in at-risk public school children.
  2. To determine whether parent education and involvement improves outcome in anxious children treated with CBT.
  3. To determine the ability of school personnel in a) recognizing classroom behaviors as anxiety disordered after targeting training of observable child behaviors e.g., avoidance, over-worry, etc.), and b) delivering a cognitive behavior intervention and
  4. To evaluate a new measure of teacher-rated anxiety disorder symptoms in children.

Hypothesis:

  1. A CBT oriented intervention as delivered by school personnel will be superior to an attention control procedure in reducing anxiety symptoms in at-risk children.
  2. Children who have parental involvement will post stronger and more enduring treatment gains.

Condition or disease Intervention/treatment Phase
Anxiety Behavioral: Cognitive Behaviour Treatment Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 281 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Primary Purpose: Prevention
Official Title: VP3: Vancouver Primary Prevention Program (Anxiety Disorders Prevention in School Children)
Study Start Date : November 2002
Study Completion Date : June 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety




Primary Outcome Measures :
  1. Anxiety symptoms


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   7 Years to 13 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Children enrolled in school between the ages of 7 and 13 who display anxiety symptoms.

  1. Anxiety disorder symptoms (identified by a score of 56 or higher on the MASC; and teacher report, and /or parent recommendation) as the primary presenting problem. An enrolled child must have at least 2 of these criterions.
  2. Fluency in English.
  3. Parent willingness to sign consent form and to complete required assessments.
  4. Student willingness to participate (child assent) in 10-week affective education program and completion of required assessments.

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00247754


Locations
Layout table for location information
Canada, British Columbia
University of British Columbia, Faculty of Education
Vancouver, British Columbia, Canada, V6T 1Z4
Sponsors and Collaborators
University of British Columbia
Canadian Institutes of Health Research (CIHR)
Investigators
Layout table for investigator information
Principal Investigator: Lynn Miller, PhD, R.Psych. University of British Columbia
Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00247754    
Other Study ID Numbers: B01-0072
First Posted: November 2, 2005    Key Record Dates
Last Update Posted: November 2, 2005
Last Verified: October 2005
Keywords provided by University of British Columbia:
Anxiety
Therapy
Behaviour
Additional relevant MeSH terms:
Layout table for MeSH terms
Anxiety Disorders
Mental Disorders